Filing Details

Accession Number:
0001628280-23-033504
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-02 17:04:23
Reporting Period:
2023-09-24
Accepted Time:
2023-10-02 17:04:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
834365 Biolife Solutions Inc BLFS Electromedical & Electrotherapeutic Apparatus (3845) 943076866
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1556355 J. Aby Mathew 3303 Monte Villa Parkway
Suite 310
Bothell WA 98021
Evp & Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-24 802 $0.00 273,780 No 4 A Direct
Common Stock Disposition 2023-09-28 659 $14.16 273,121 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant.
  2. The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-25-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.